BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25281591)

  • 1. siRNA nanotherapeutics: a Trojan horse approach against HIV.
    Mishra V; Kesharwani P; Jain NK
    Drug Discov Today; 2014 Dec; 19(12):1913-20. PubMed ID: 25281591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
    Bolhassani A; Milani A
    Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.
    Adesina SK; Akala EO
    Mol Pharm; 2015 Dec; 12(12):4175-87. PubMed ID: 26524196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapies for HIV with RNAi.
    Nekhai S; Jerebtsova M
    Curr Opin Mol Ther; 2006 Feb; 8(1):52-61. PubMed ID: 16506526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo.
    Choi KM; Kim K; Kwon IC; Kim IS; Ahn HJ
    Mol Pharm; 2013 Jan; 10(1):18-25. PubMed ID: 22663765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference as an antiviral approach: targeting HIV-1.
    Berkhout B
    Curr Opin Mol Ther; 2004 Apr; 6(2):141-5. PubMed ID: 15195925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of non-viral vectors for siRNA delivery].
    Yang FF; Huang W; Li YF; Gao ZG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of HIV-1 replication by RNA interference.
    Lee NS; Rossi JJ
    Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress towards therapeutic application of RNA interference for HIV infection.
    Singh SK; Gaur RK
    BioDrugs; 2009; 23(5):269-76. PubMed ID: 19754217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Based Combination Therapy for Cancer Treatment.
    Yhee JY; Son S; Lee H; Kim K
    Curr Pharm Des; 2015; 21(22):3158-66. PubMed ID: 26027570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy strategies to block HIV-1 replication by RNA interference.
    Herrera-Carrillo E; Berkhout B
    Adv Exp Med Biol; 2015; 848():71-95. PubMed ID: 25757616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
    Akhtar S
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1347-62. PubMed ID: 20929276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of HIV infection: gene therapy and RNA interference.
    Delgado R; Regueiro BJ
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():68-83. PubMed ID: 16373006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo delivery of RNAi with lipid-based nanoparticles.
    Huang L; Liu Y
    Annu Rev Biomed Eng; 2011 Aug; 13():507-30. PubMed ID: 21639780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.